IPP Bureau
Aurobindo Pharma posts consolidated Q1FY23 PAT of Rs. 520.54 Cr
By IPP Bureau - August 12, 2022
The company has reported total income of Rs. 6276.54 crores during the period ended June 30, 2022.
S. Sridhar resigns as Managing Director of Pfizer
By IPP Bureau - August 11, 2022
Sridhar will continue to serve in his current position of Managing Director for as long a period as required until the identification, selection and transition to the new leadership takes place in the company.
Lincoln Pharmaceuticals Q1 FY23 consolidated profit up at Rs. 15.01 Cr
By IPP Bureau - August 11, 2022
The company has reported total income of Rs. 129.96 crores during the period ended June 30, 2022.
Agriculture Minister Narendra Singh Tomar launches indigenous vaccine for Lumpy Skin disease
By IPP Bureau - August 11, 2022
The vaccine has been developed by the National Equine Research Center, Hisar (Haryana) in collaboration with the Indian Veterinary Research Institute, Izzatnagar (Bareilly)
IPCA Laboratories Q1 FY23 consolidated PAT higher at Rs. 143.06 Cr
By IPP Bureau - August 11, 2022
The company has reported total income of Rs. 1607.85 crores during the period ended June 30, 2022.
Max Healthcare Institute Q1 FY23 consolidated PAT soars at Rs. 172.83 Cr
By IPP Bureau - August 11, 2022
The company has reported total income of Rs. 1097.78 crores during the period ended June 30, 2022.
Zydus Lifesciences Q1 FY23 consolidated PAT up at Rs. 518.3 Cr
By IPP Bureau - August 11, 2022
The company has reported total income of Rs. 4138.6 crores during the period ended June 30, 2022.
AI to shape future outcomes in cardiovascular care, says GlobalData
By IPP Bureau - August 11, 2022
AI-driven company anumana partnered with Novartis to drive the development of its electrocardiogram (ECG) AI algorithms to detect subclinical heart disease.
Vijaya Diagnostic Centre Q1 FY23 revenue down 14.9%
By IPP Bureau - August 10, 2022
EBITDA stood at Rs. 39.9 crore and EBITDA margin for the quarter was 38.2% whereas Profit After Tax (PAT) stood at Rs. 17.5 crore translating into a PAT margin of 16.7%
Natco Pharma appoints Dr. Pavan Ganapati Bhat as Executive Director
By IPP Bureau - August 10, 2022
He has over 25+ years of experience in the pharmaceutical Industry and has been working with the company for the past 6 years
Sri Lankan President welcomes opening of free hospital by Sri Sathya Sai Baba Trust
By IPP Bureau - August 10, 2022
The Sri Sathya Sai Sanjeevani Super Speciality Hospital in Batticaloa will begin its operations by conducting free paediatric cardiac care surgeries and interventions in the next few days
Natco Pharma consolidated Q1FY23 PAT jumps to Rs. 320.4 Cr
By IPP Bureau - August 10, 2022
The company has reported total income of Rs. 918.9 crores during the period ended June 30, 2022.
Unichem Laboratories Q1 FY23 consolidated loss at Rs. 23.36 Cr
By IPP Bureau - August 10, 2022
The company has reported total income of Rs. 317.45 crores during the period ended June 30, 2022
Margin disappointment continues for Lupin in Q1FY23 : Prabhudas Lilladher
By IPP Bureau - August 09, 2022
Margins under pressure - Price erosion, shelf stock adjustments and inventory pare down in US biz impacted margins.
Fortis Healthcare posts Q1 FY2023 consolidated PAT at Rs. 122.25 Cr
By IPP Bureau - August 09, 2022
The company has reported total income of Rs. 1508.55 crores during the period ended June 30, 2022.
